Unique Approach for the Study of Immune System Funcionality
An Italian company can provide a unique, sensitive and specific approach for the study of Immune System Functionality through Enzyme-Linked ImmunoSPOT and Precursor with High Proliferative Capacity (PHPC) methodologies; the approach has been recently validated by the Italian Drug Agency. As a laboratory certified to conduct immunology assays within the context of Phase I clinical trials, the company is open to technical cooperation agreements, service agreements or research agreements.
The owner of the profile is looking for companies, research centers or universities willing to test immune response in human samples derived from drug development or vaccine development programs in infectious disease (viral infection or parasitic infections), oncology, transplantation programs, through Technical cooperation agreements, research cooperation agreements or service agreements.
Within immune system functionality studies, Enzyme-Linked Immunospot (ELISpot), detects the Effector T cells cytokines secretion with an in vitro system that closely resembles the in vivo immune biology, thus allowing immune response monitoring. ELISpot goes beyond the limits of the Eenzyme-Linked Immunosorbent Assay methodology (ELISA), that only indirectly measures cytokines, overcomes the high cell number needed for flow cytometry and, compared to Intracellular Cytokines Staining (ICS), ELISpot offers a better evaluation of the full efficiency of cytokines secretion, as intracellular staining could monitor a protein that maybe will be not released. ELISpot offers the best point of view for ex vivo Effector T cells monitoring, with application in: • Drug development • Vaccine development • Transplantation PHPC, similarly to ELISpot, detecting the T cells cytokines secretion with an in vitro system that closely resembles the in vivo immune biology, allows immune response monitoring in many fields of immune system functionality studies. PHPC offers the best point of view for ex vivo monitoring of Central Memory T cells, again with application in: • Drug development • Vaccine development • Transplantation Application: nowadays, ELISpot offers the best point of view for ex vivo Effector T cells monitoring, with application in: • DRUG DEVELOPMENT: ELISpot permits to assess the immunogenicity of biotherapeutics avoiding molecules that could trigger an unwanted activation of immune system. • VACCINE DEVELOPMENT: ELISpot permits to evaluate the immune response induced after administration of vaccine candidates. o Cancer Vaccine (Butterfield et al. 2014) o Infectious Disease Vaccine (Calarota et al. 2007) • TRANSPLANTATION: Assessment of donor-specific T cell immunity pre- and post-transplant permit to identify patient with major risk of rejection and to identify immunosuppressive therapy. The company offers its own developments in methodologies for advancements in the mentioned fields and is ready for cooperation agreements.
Advantages and innovations
The company was recently inserted in the list of authorized laboratory certified to conduct immunology assays within the context of Phase I clinical trials. The company can perform these immunology assays as a fee-for-service for any research center, company or university, interested in evaluating immune response in human samples deriving from drug development (e.g. immune-oncology drugs) or vaccine development programs.
Intellectual Property Rights (IPR)
Register your interest
How it works
- Tell us about yourself
- We’ll discuss with you
- We put the right partners in touch
EEN help you find the right partner, rather than you going it alone.
Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.
These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.
Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.
First we need to check you’re human.
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to unlock the form below